S100A14, which has been shown to exert tumor-suppressive effects in gastrointestinal cancers [26], was upregulated in a dose-dependent manner in HCT116-GFP cells while a dose-dependent decrease was observed in PBMCs. This evidence concerns the gene S100A14 and neoplasm.